Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant
- 25 April 2005
- Vol. 23 (31) , 4029-4035
- https://doi.org/10.1016/j.vaccine.2005.03.028
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Botulinum and tetanus neurotoxins: structure, function and therapeutic utilityTrends in Biochemical Sciences, 2002
- Recovery of intracellular recombinant proteins from the yeast Pichia pastoris by cell permeabilizationJournal of Biotechnology, 2002
- Initial purification of recombinant botulinum neurotoxin fragments for pharmaceutical production using hydrophobic charge induction chromatographyJournal of Chromatography A, 2002
- Development of vaccines for prevention of botulismBiochimie, 2000
- Production and Purification of the Heavy Chain Fragment C of Botulinum Neurotoxin, Serotype A, Expressed in the Methylotrophic Yeast Pichia pastorisProtein Expression and Purification, 2000
- Development of recombinant vaccines for botulinum neurotoxinToxicon, 1998
- Production and Purification of the Heavy-Chain Fragment C of Botulinum Neurotoxin, Serotype B, Expressed in the Methylotrophic YeastPichia pastorisProtein Expression and Purification, 1998
- Clinical spectrum of botulismMuscle & Nerve, 1998
- Structure and Function of Clostridium botulinum ToxinsMicrobiology and Immunology, 1995
- Mechanism of action of tetanus and botulinum neurotoxinsMolecular Microbiology, 1994